Biotechnology Investment fund raises stake in private companies
This article was originally published in Clinica
Biotechnology Investment Limited (BIL), one of the UK's few investment companies concentrating on development-stage companies in the biotechnology sector, saw its investments in quoted companies fall by 38% in value, to $204 million last year. Its investments in private companies rose, however, by 7%, to $83 million.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.